CVS

Why Are People Talking About Investing in CVS Health (CVS)?

Shares of Large-cap consumer staples company CVS Health moved -0.0 this evening, and are now trading at $78.94 per share. On the other hand, the average analyst target price for the stock is $87.39.

CVS Health Corporation provides health services in the United States.

CVS Health Investors Should Consider This:

  • CVS Health has moved -15.3% over the last year.

  • The company has a price to earnings growth (PEG) ratio of 3.93. A number between 0 and 1 could mean that the market is undervaluing CVS Health's estimated growth potential

  • Its Price to Book (P/B) ratio is 1.37

  • CVS Health currently returns an annual dividend yield of 3.0%.

Understanding CVS Health's Operating Margins

Date Reported Total Revenue ($ k) Operating Expenses ($ k) Operating Margins (%) YoY Growth (%)
2023 347,809,000 333,780,000 4 100.0
2022 322,467,000 314,513,000 2 -60.0
2021 292,111,000 278,801,000 5 0.0
2020 268,706,000 254,795,000 5 0.0
2019 256,776,000 244,789,000 5 150.0
2018 194,579,000 190,558,000 2

Over the last 6 years, CVS Health's operating margins have averaged 3.8%, which is similar to the 4.35% Pharmaceutical Retail industry average. We also note that the company's operating margins have a high coefficient of variability at 2216.62%. On the other hand, we note that the firm's margins are growing at a 12.4% compounded average yearly rate.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS